Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Cooper-White

APL bioengineering

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
APL Bioengineering|May 10, 2019
Editorial: Welcome to <i>APL Bioengineering</i>Justin Cooper-White
APL Bioengineering|March 13, 2020
Bioengineering of the heartAlberto Redaelli, Justin Cooper-White
APL Bioengineering|March 13, 2020
Academic vs industry perspectives in 3D bioprintingAdam J Engler, Justin Cooper-White
APL Bioengineering|May 14, 2023
The role of biomechanical factors in models of intervertebral disc degeneration across multiple length scalesDaniela Lazaro-Pacheco, Mina Mohseni, Samuel Rudd, et al.
APL Bioengineering|May 10, 2019
Modelling ischemia-reperfusion injury (IRI) <i>in vitro</i> using metabolically matured induced pluripotent stem cell-derived cardiomyocytesAlejandro Hidalgo, Nick Glass, Dmitry Ovchinnikov, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
APL Bioengineering|May 10, 2019
Editorial: Welcome to <i>APL Bioengineering</i>Justin Cooper-White
APL Bioengineering|March 13, 2020
Bioengineering of the heartAlberto Redaelli, Justin Cooper-White
APL Bioengineering|March 13, 2020
Academic vs industry perspectives in 3D bioprintingAdam J Engler, Justin Cooper-White
APL Bioengineering|May 14, 2023
The role of biomechanical factors in models of intervertebral disc degeneration across multiple length scalesDaniela Lazaro-Pacheco, Mina Mohseni, Samuel Rudd, et al.
APL Bioengineering|May 10, 2019
Modelling ischemia-reperfusion injury (IRI) <i>in vitro</i> using metabolically matured induced pluripotent stem cell-derived cardiomyocytesAlejandro Hidalgo, Nick Glass, Dmitry Ovchinnikov, et al.
Pageof 1